RAD Biomed Fund I

RAD Biomed

Status

ACTIVE

Global HQ

Israel

Countries of investment

Israel

Investment stages

Pre-Seed
Seed

Industries

Health Tech
Biotechnology
AI
Fintech

About
RAD Biomed is a pioneering investment firm dedicated to advancing early-stage digital health and medical device ventures in Israel. With a keen focus on innovation, the company is also at the forefront of developing an AI-driven test and decision support tool designed to enhance the rapid diagnosis of stroke and large vessel occlusion in emergency room settings. By leveraging cutting-edge technology and a deep understanding of the healthcare landscape, RAD Biomed aims to improve patient outcomes and streamline emergency medical responses. Through strategic investments and collaborations, RAD Biomed is committed to shaping the future of healthcare delivery.

Min check size: $250K
Max check size: $5M
Fund size: Unlock
NPS: Unlock

Investment Thesis

RAD Biomed invests in early stage digital health and medical device ventures based in Israel. The firm seeks out companies with disruptive new solutions to realworld challenges and unmet needs.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

With a strong background in the healthcare and technology sectors, the fund manager has successfully led over 30 investments across North America and Europe. Their approach emphasizes a data-driven strategy, focusing on early to growth-stage companies that exhibit strong potential for scalability. Notable exits include several high-profile IPOs and acquisitions that underscore their ability to identify and nurture promising startups. The manager’s operator-first philosophy fosters deep partnerships with portfolio companies, ensuring alignment on strategic objectives and operational execution.